Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Regional Differences in Secondary Prevention Therapy—Geography Should Not Be Destiny

Regional Differences in Secondary Prevention Therapy—Geography Should Not Be Destiny Use of High-Intensity Statins After MI Among Medicare Beneficiaries Original Investigation Research Editor's Note Regional Differences in Secondary Prevention Therapy— Geography Should Not Be Destiny Ann Marie Navar, MD, PhD; Gregg C. Fonarow, MD Statin therapy is a cornerstone of secondary prevention higher for patients seen in academic medical centers, larger in adults with atherosclerotic cardiovascular disease; it re- hospitals, and not-for-profit hospitals. In multivariable mod- duces the risk of subsequent myocardial infarction, stroke, eling, however, the factor most associated with high- revascularization, and cardio- intensity statin use was census region. Rates of high- vascular death. Because of intensity statin use varied almost 2-fold from the poorest- Related article page 865 their greater efficacy com- performing region (the West South Central region; 41%) to the pared with moderate-inten- highest-performing region (New England; 73.5%). While this sity statins, high-intensity statins received a class I recom- study did not evaluate outcomes, these gaps correspond with mendation for adults 75 years and younger with atherosclerotic known regional differences in cardiovascular mortality. Of the cardiovascular disease in the 2013 American College of Cardi- 4 states in the West South Central region, 3 were ranked in the ology/American Heart Association cholesterol guidelines. top 5 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Regional Differences in Secondary Prevention Therapy—Geography Should Not Be Destiny

Navar, Ann Marie; Fonarow, Gregg C.
JAMA Cardiology , Volume 4 (9) – Sep 24, 2019
Download PDF
1 page
Read Article

Regional Differences in Secondary Prevention Therapy—Geography Should Not Be Destiny

Abstract

Use of High-Intensity Statins After MI Among Medicare Beneficiaries Original Investigation Research Editor's Note Regional Differences in Secondary Prevention Therapy— Geography Should Not Be Destiny Ann Marie Navar, MD, PhD; Gregg C. Fonarow, MD Statin therapy is a cornerstone of secondary prevention higher for patients seen in academic medical centers, larger in adults with atherosclerotic cardiovascular disease; it re- hospitals, and not-for-profit hospitals. In multivariable...
Loading next page...
 
/lp/american-medical-association/regional-differences-in-secondary-prevention-therapy-geography-should-qmy4rjhUjc
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2019.2548
Publisher site
See Article on Publisher Site

Abstract

Use of High-Intensity Statins After MI Among Medicare Beneficiaries Original Investigation Research Editor's Note Regional Differences in Secondary Prevention Therapy— Geography Should Not Be Destiny Ann Marie Navar, MD, PhD; Gregg C. Fonarow, MD Statin therapy is a cornerstone of secondary prevention higher for patients seen in academic medical centers, larger in adults with atherosclerotic cardiovascular disease; it re- hospitals, and not-for-profit hospitals. In multivariable mod- duces the risk of subsequent myocardial infarction, stroke, eling, however, the factor most associated with high- revascularization, and cardio- intensity statin use was census region. Rates of high- vascular death. Because of intensity statin use varied almost 2-fold from the poorest- Related article page 865 their greater efficacy com- performing region (the West South Central region; 41%) to the pared with moderate-inten- highest-performing region (New England; 73.5%). While this sity statins, high-intensity statins received a class I recom- study did not evaluate outcomes, these gaps correspond with mendation for adults 75 years and younger with atherosclerotic known regional differences in cardiovascular mortality. Of the cardiovascular disease in the 2013 American College of Cardi- 4 states in the West South Central region, 3 were ranked in the ology/American Heart Association cholesterol guidelines. top 5

Journal

JAMA Cardiology – American Medical Association

Published: Sep 24, 2019

References

  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials
    Baigent, C; Blackwell, L; Emberson, J
  • Association of region and hospital and patient characteristics with use of high-intensity statins after myocardial infarction among Medicare beneficiaries
    Bittner, V; Colantonio, LD; Dai, Y